What’s the basic cure for regenerative obstructive anaemia?

The basic cure for regenerative obstructive anaemia (Aplastic Anemia, AA) is a blood disease caused by bone marrow blood function disorders, characterized by a decrease in the whole blood cell, including erythrocytes, white cells and slabs. For AA patients, “basic healing” is a relative concept, as there is currently no absolute medical cure, but a degree of relief can be achieved through treatment to enable the patient to return to normal life. The following is a detailed explanation of how people with regenerative obstructive anaemia count as the basic cure:1. Treatment effectiveness assessment criteriaThe efficacy assessment of regenerative obstructive anaemia is usually based on the following criteria:a. National and international standards:- Total mitigation (CR): Hb)110g/L, absolute value of neutral particles (ANC)1.5×10.9/L, blood plate (PLT)100×10.9/L, and these indicators are maintained for at least three months.- Partial mitigation (PR): Hb≥90g/L, ANC≥0.5×10^9/L, PLT≥20×10^9/L, and these indicators are increased by at least 50% and maintained for at least three months before treatment.- Ineffective: Not meeting partial mitigation criteria.b. Long-term efficacy assessment:- Continuous relief: from the beginning of treatment, after the patient has reached CR or PR, no blood transfusion or other treatment is required to last at least two years.- Healing: Upon reaching CR, the patient does not need any treatment and lasts at least five years.2. Signs of basic healingPersons suffering from regenerative obstructive anaemia can be considered to have the following conditions:a. Clinical symptoms and signs:- No severe anaemia: the patient ‘ s haemoglobin level has stabilized in normal range, with no apparent symptoms of lack of strength, heart attack or agitation.- No serious infection: the white cell count of the patient is stable and effective against common infections.- No severe haemorrhage: patient slab count is stable and no spontaneous haemorrhage.b. Laboratory inspection:- Normal blood: the count of haemoglobin, white cells and slabs has stabilized in the normal range over time.- Improved bone marrow: examination of bone marrow piercing shows that bone marrow growth is good and the blood cell ratio is normal.c. Treatment response:- No periodic blood transfusion is required: patients are able to maintain normal haemoglobin levels without regular blood transfusions.- There is no need for long-term medication: patients do not need long-term dependence on immunosuppressants or blood growth factors to maintain blood cell levels.d. Follow-up observations:- Long-term non-recurrence: after the end of the treatment, the patient has at least five years of follow-up and follow-up, and there is no recurrence.3. Treatment strategiesTo achieve basic healing, patients usually need the following treatment strategies:a. Treatment of immunosuppression:- The use of immunosuppressants, such as anti-mural cell protein (ATG) and cyclothylene, in order to suppress abnormal immune reactions and promote the restoration of bone marrow blood function.b. Blood stem cell transplants:- For young patients, especially those with suitable supplies, blood stem cell transplants are a potential cure for AAs.c. Support for treatment:- Measures such as blood transfusions, antibiotics and haemorrhage prevention to support patients through the first stages of treatment.d. Individualized treatment:- Development of individualized treatment programmes, taking into account, inter alia, the age of the patient, the severity of the illness and the complications.4. Quality of life assessmentIn addition to clinical and laboratory indicators, the quality of life of patients is an important aspect of assessing basic healing:a. Social functions:- The ability of patients to return to normal work, study and social activities.- Patients are able to exercise a reasonable amount of physical activity, without obvious physical constraints.(b) Psychological state:- Patients are able to respond well to the psychological stress of the disease and remain positive and optimistic.ConclusionsThe basic treatment standard for patients with regenerative obstructive anaemia is a comprehensive assessment, including the improvement of clinical symptoms, the stability of laboratory indicators, the persistence of treatment responses and the improvement of the quality of life. Although it is not yet possible to cure AA completely, with reasonable treatment, many patients can achieve long-term relief and live near normal lives. Patients should conduct regular follow-up visits and examinations, under the guidance of a doctor, in order to monitor changes in conditions and adjust treatment programmes in a timely manner.